Comprehensive Neuroscience. Inc.

Washington D.C., District of Columbia 20016

0 studies enrolling now · 8 studies all time

What they study most

Chronic Schizophrenia, Major Depressive Disorder, Psychotic Disorders, Schizoaffective Disorder, Schizophrenia

Studies at this site

• A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia — Completed
• Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. — Completed
• Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia — Completed
• Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia — Completed
• Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia — Completed
• A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia — Completed
• A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia — Completed
• A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression — Completed